[-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study
Author:
Affiliation:
1. Department of Urology, Northwestern University, Chicago, Illinois
2. Department of Urology, Johns Hopkins, Baltimore, Maryland
3. Department of Pathology, University of Illinois at Chicago, Chicago, Illinois
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference28 articles.
1. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N Engl J Med,1991
2. The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration;Tchetgen;Urol Clin North Am,1997
3. The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen;Emiliozzi;J Urol,2001
4. Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml;Okihara;J Urol,2001
5. Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0 ng/ml range;Roehl;J Urol,2002
Cited by 130 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia;Journal of Ethnopharmacology;2024-08
2. Established and emerging liquid biomarkers for prostate cancer detection: A review;Urologic Oncology: Seminars and Original Investigations;2024-06
3. Nomogram Using Prostate Health Index for Predicting Prostate Cancer in the Gray Zone: Prospective, Multicenter Study;The World Journal of Men's Health;2024
4. Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer;Biomedicines;2023-07-06
5. Capitalizing glycomic changes for improved biomarker-based cancer diagnostics;Exploration of Targeted Anti-tumor Therapy;2023-06-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3